Optimum experimental designs for comparative bioavailability studies
From MaRDI portal
Recommendations
- Publication:4410316
- Design and Analysis of Bioavailability and Bioequivalence Studies
- Publication:3835818
- Optimal designs for dose-finding experiments in toxicity studies
- Optimal experimental designs for estimating the drug combination index in toxicology
- Optimal designs for dose-finding studies
- Optimal parametric design with applications to pharmacokinetic and pharmacodynamic trials
- Publication:4227086
Cites work
- scientific article; zbMATH DE number 3943824 (Why is no real title available?)
- scientific article; zbMATH DE number 3490283 (Why is no real title available?)
- scientific article; zbMATH DE number 3352656 (Why is no real title available?)
- scientific article; zbMATH DE number 3052150 (Why is no real title available?)
- Pairwise-balanced, variance-balanced and resistant incomplete block designs revisited
- Resistant and susceptible BIB designs
Cited in
(5)- Optimal adaptive designs for acute oral toxicity assessment
- Optimal experimental designs for estimating the drug combination index in toxicology
- Optimal 3×3 factorial and 3-ray designs for drug interaction experiments with dichotomous responses
- A bound for efficiency in multiple response designs
- Experimental designs for the estimation of the concentration curve and the AUC
This page was built for publication: Optimum experimental designs for comparative bioavailability studies
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q1338369)